@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP898076.RAPItWrT2c4tAl5LiTy55C-7X69z9UhCDBZJ7aATeFFuc130_head { this: np:hasAssertion dgn-np:NP898076.RAPItWrT2c4tAl5LiTy55C-7X69z9UhCDBZJ7aATeFFuc130_assertion; np:hasProvenance dgn-np:NP898076.RAPItWrT2c4tAl5LiTy55C-7X69z9UhCDBZJ7aATeFFuc130_provenance; np:hasPublicationInfo dgn-np:NP898076.RAPItWrT2c4tAl5LiTy55C-7X69z9UhCDBZJ7aATeFFuc130_publicationInfo; a np:Nanopublication . dgn-np:NP898076.RAPItWrT2c4tAl5LiTy55C-7X69z9UhCDBZJ7aATeFFuc130_assertion a np:Assertion . dgn-np:NP898076.RAPItWrT2c4tAl5LiTy55C-7X69z9UhCDBZJ7aATeFFuc130_provenance a np:Provenance . dgn-np:NP898076.RAPItWrT2c4tAl5LiTy55C-7X69z9UhCDBZJ7aATeFFuc130_publicationInfo a np:PublicationInfo . } dgn-np:NP898076.RAPItWrT2c4tAl5LiTy55C-7X69z9UhCDBZJ7aATeFFuc130_assertion { miriam-gene:50616 a ncit:C16612 . lld:C1140680 a ncit:C7057 . dgn-gda:DGNf702963f094ec9cc7620bf3d017fc3b2 sio:SIO_000628 miriam-gene:50616, lld:C1140680; a sio:SIO_001121 . } dgn-np:NP898076.RAPItWrT2c4tAl5LiTy55C-7X69z9UhCDBZJ7aATeFFuc130_provenance { dgn-np:NP898076.RAPItWrT2c4tAl5LiTy55C-7X69z9UhCDBZJ7aATeFFuc130_assertion dcterms:description "[Our results show that i) aPC induced the secretion of several cytokines in Ovcar-3 cells; ii) 61% of patients exhibited a concentration of plasma sEPCR well above the baseline (normal plasma level, 100 ± 28 ng/ml); iii) comparing immune cell phenotypes in patients having a normal level of sEPCR with those having a high level of sEPCR, it was found that sEPCR levels were correlated with high intensity of cells expressing CD45ra, CD3, CD8, CD25 and low intensity of cells expressing CD56 (NK cells), CD294 (TH2 cells), IL-2, IL-10, IL-17a (TH17 cells), IL-21 (TH21 cells) and CD29 markers (r ≥ 0.60); and iv) high levels of sEPCR correlate with high levels of plasma bioactive proteins such as insulin-like growth factor-2 (IGFII), IL-13rα, macrophage inflammatory protein (MIP1α) and matrix metalloproteinase-7 (MMP-7) that have already been proposed as biomarkers for ovarian cancer and particularly those with poor prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:23877403; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP898076.RAPItWrT2c4tAl5LiTy55C-7X69z9UhCDBZJ7aATeFFuc130_publicationInfo { this: dcterms:created "2015-08-25T14:46:48+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }